Sho Kato
Tsu, 5148507, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CTLA-4Ig Improves Hyperalgesia in a Mouse Model of Osteoporosis.
Journal: International journal of molecular sciences
Published: November 20, 2020
Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.
Journal: Modern rheumatology
Published: July 11, 2020
Functional Block of Interleukin-6 Reduces a Bone Pain Marker but Not Bone Loss in Hindlimb-Unloaded Mice.
Journal: International journal of molecular sciences
Published: April 03, 2020
Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice.
Journal: Journal of orthopaedic surgery (Hong Kong)
Published: December 14, 2019
Interleukin-6 Inhibitor Suppresses Hyperalgesia Without Improvement in Osteoporosis in a Mouse Pain Model of Osteoporosis.
Journal: Calcified tissue international
Published: November 12, 2018
The effects of bisphosphonate on pain-related behavior and immunohistochemical analyses in hindlimb-unloaded mice.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
Published: February 02, 2018
Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.
Journal: Breast cancer (Tokyo, Japan)
Published: September 19, 2017
Alendronate inhibits hyperalgesia and suppresses neuropeptide markers of pain in a mouse model of osteoporosis.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
Published: October 03, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026